tradingkey.logo
搜索

Bausch + Lomb Corp

BLCO
添加自选
16.540USD
-0.090-0.54%
收盘 06/30, 16:00美东报价延迟15分钟
5.86B总市值
亏损市盈率 TTM

关于 Bausch + Lomb Corp 公司

Bausch + Lomb Corporation is an eye health company. It operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.

Bausch + Lomb Corp简介

公司代码BLCO
公司名称Bausch + Lomb Corp
上市日期May 06, 2022
CEOSaunders (Brenton L)
员工数量13500
证券类型Ordinary Share
年结日May 06
公司地址520 Applewood Crescent
城市VAUGHAN
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家Canada
邮编L4K 4B4
电话19082552864
网址https://ir.bausch.com/
公司代码BLCO
上市日期May 06, 2022
CEOSaunders (Brenton L)

Bausch + Lomb Corp公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Luc Bonnefoy
Mr. Luc Bonnefoy
President - Surgical
President - Surgical
87.02K
-1.16%
Dr. Yehia Hashad, M.D.
Dr. Yehia Hashad, M.D.
Executive Vice President - Research & Development, Chief Medical Officer
Executive Vice President - Research & Development, Chief Medical Officer
72.80K
-18.77%
Karen Ling ,
Karen Ling ,
Independent Director
Independent Director
57.52K
+62.90%
Mr. Russel C. Robertson
Mr. Russel C. Robertson
Independent Director
Independent Director
27.66K
+57.27%
Mr. Sam A. Eldessouky
Mr. Sam A. Eldessouky
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mr. Thomas W. Ross, Sr.
Mr. Thomas W. Ross, Sr.
Lead Independent Director
Lead Independent Director
--
--
Mrs. Nathalie Bernier
Mrs. Nathalie Bernier
Independent Director
Independent Director
--
--
Dr. Andrew Charles Von Eschenbach, M.D.
Dr. Andrew Charles Von Eschenbach, M.D.
Independent Director
Independent Director
--
--
Ms. Sarah B. Kavanagh
Ms. Sarah B. Kavanagh
Independent Director
Independent Director
--
--
Mr. John A. Paulson ,
Mr. John A. Paulson ,
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Luc Bonnefoy
Mr. Luc Bonnefoy
President - Surgical
President - Surgical
87.02K
-1.16%
Dr. Yehia Hashad, M.D.
Dr. Yehia Hashad, M.D.
Executive Vice President - Research & Development, Chief Medical Officer
Executive Vice President - Research & Development, Chief Medical Officer
72.80K
-18.77%
Karen Ling ,
Karen Ling ,
Independent Director
Independent Director
57.52K
+62.90%
Mr. Russel C. Robertson
Mr. Russel C. Robertson
Independent Director
Independent Director
27.66K
+57.27%
Mr. Sam A. Eldessouky
Mr. Sam A. Eldessouky
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mr. Thomas W. Ross, Sr.
Mr. Thomas W. Ross, Sr.
Lead Independent Director
Lead Independent Director
--
--

常见问题

Bausch + Lomb Corp的前五大股东是谁?

Bausch + Lomb Corp 的前五大股东如下:Mr. Luc Bonnefoy

有多少机构持有Bausch + Lomb Corp(BLCO)的股份?

截至2026Q1,共有249家机构持有Bausch + Lomb Corp的股份,合计持有的股份价值约为40.30M,占公司总股份的11.30%。与2025Q4相比,机构持股有所增加,增幅为-25007155.00。

哪个业务部门对Bausch + Lomb Corp的收入贡献最大?

在2026Q1,Devices业务部门对Bausch + Lomb Corp的收入贡献最大,创收1.92B,占总收入的37.68%。
KeyAI